Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Know Labs Inc (OP: KNWN )

N/A UNCHANGED
Last Price Updated: 3:59 PM EDT, Sep 15, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Know Labs Inc

Know Labs, Inc. Announces NYSE American Listing Approval
From Know Labs, Inc.
Via Business Wire
Know Labs Provides Update on IRB-Approved Internal Trial of Non-Invasive Glucose Monitoring Technology
From Know Labs, Inc.
Via Business Wire
Millions Suffering From Diabetes May Soon See Relief From Some Of The Pain And Expenses Associated
Americans with diabetes have been relying on insulin injections to manage their illness for decades. Those injections can be painful, expensive and inconvenient. The daily invasive testing regimen adds... 
Via TheNewswire.com
Exposures Product Safety
Know Labs Files S-1 for New Share Offering, Seeks Uplist to NYSE American Exchange
From Know Labs, Inc.
Via Business Wire
Know Labs Expands Leadership Team, Adds Chief Financial Officer and Chief Product Officer, As It Gets Closer to FDA Clearance Application
From Know Labs, Inc.
Via Business Wire
Know Labs, Inc. Discusses Significance of Patented Non-Invasive Blood Glucose Monitoring Technology with The Stock Day Podcast
Phoenix, Arizona--(Newsfile Corp. - May 10, 2022) - The Stock Day Podcast welcomed Know Labs, Inc. (OTCQB: KNWN) ("the Company"),... 
Via Newsfile
Exposures Product Safety
New Foundational Patents Secure Multiple Growth Opportunities for Know Labs and Its Bio-RFID™ Non-Invasive Diagnostic Technology
From Know Labs, Inc.
Via Business Wire
Know Labs Receives IRB Approval to Begin Internal Clinical Trial of Non-Invasive Glucose Monitoring Technology Bio-RFID™
From Know Labs, Inc.
Via Business Wire
Know Labs Launches Subsidiary, AI Mind Inc., Generates $4.2M in NFT Revenue to Fund Continued Non-Invasive Glucose Monitoring Device Development
From Know Labs, Inc.
Via Business Wire
New Test Data Confirm Particle™ Bulb from Know Labs Successfully Inactivates SARS-CoV-2 Variants
From Know Labs, Inc.
Via Business Wire
New Tests Show Know Labs Bio-RFID™ Technology Delivers Blood Glucose Readings Comparable to FDA-Cleared Devices
From Know Labs, Inc.
Via Business Wire
Know Labs Expands Non-Invasive Glucose Monitoring Product Portfolio with Introduction of New KnowU™ Diagnostic Device
From Know Labs, Inc.
Via Business Wire
Three New Patents for Know Labs Expand IP Portfolio and Signal Further Applications for Bio-RFID™
From Know Labs, Inc.
Via Business Wire
New Patent for Know Labs Marks Latest Step Toward Commercial Launch of Bio-RFIDTM Non-Invasive Medical Diagnostic Technology
From Know Labs, Inc.
Via Business Wire
Know Labs Receives New Patent for Its Non-Invasive Diagnostic Technology Platform, Bringing Patents Issued and Pending to Nearly 60
From Know Labs, Inc.
Via Business Wire
50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021
RALEIGH, NC / ACCESSWIRE / July 8, 2021 / Access to Giving - an investor conference themed around investor education and advocacy begins next week, July 13th - 15th, 2021. More than 50 companies are... 
From Access to Giving
Via AccessWire
Know Labs Announces Successful Results from Pre-Clinical Study Validating Bio-RFID™ Platform Technology
From Know Labs, Inc.
Via Business Wire
50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021
RALEIGH, NC / ACCESSWIRE / June 23, 2021 / Access to Giving - an investor conference themed around investor education and advocacy is set for July 13-15, 2021. There will be 50+ companies conducting... 
From Access to Giving
Via AccessWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.